Archives
Nav1.5 Ser571 Phosphorylation in Aging Hearts
2026-09-25
This study links Nav1.5 phosphorylation at Ser571 and increased late sodium current to prolonged ventricular repolarization, impaired diastolic filling, and slower calcium and mechanical relaxation during aging. By comparing gain- and loss-of-function mouse models with aged wild-type animals, it provides evidence that late sodium current is a modifiable contributor to aging-related cardiac dysfunction, while leaving important questions about human relevance and treatment unanswered.
Isradipine (Dynacirc) for Calcium Channel Research
2026-09-24
Use Isradipine (Dynacirc) to test how L-type calcium entry contributes to vascular smooth muscle responses and neuronal calcium handling. A subtype-aware workflow, matched vehicle controls, and electrophysiology or calcium imaging help distinguish L-type effects from the mixed neuronal channel populations highlighted in the reference study.
Psora 4: Reading Kv1.3 Blockade in Immune Assays
2026-09-24
Psora 4 is a potent Kv1.3 blocker for investigating how channel inhibition shapes T-cell calcium signaling and immune function. This article connects channel pharmacology to functional readouts, highlighting how KCNE4-dependent kinetics and model context should influence assay interpretation.
ML133 HCl: Designing Rigorous Kir2.1 Experiments
2026-09-23
ML133 HCl is a selective potassium channel inhibitor for probing Kir2.1 function. This guide focuses on how to interpret its pH-dependent potency and connect channel inhibition to pulmonary artery smooth muscle cell phenotypes without overclaiming mechanism.
Tetraethylammonium Chloride (TEAC): Mechanism & Use
2026-09-23
Tetraethylammonium chloride (TEAC) is a quaternary ammonium potassium-channel pore blocker used to probe ion conduction and vascular physiology. Its internal- and external-site blocking profile supports mechanistic experiments, while product specifications define handling, solubility, and quality-control boundaries.
Phenytoin: Sodium Channel Research Guide
2026-09-22
Phenytoin, also known as 5,5-diphenylimidazolidine-2,4-dione, is a research compound used to study voltage-gated sodium channel behavior and electrophysiological signaling. Supplier specifications define its identity, solvent compatibility, storage requirements, and approximately 98–99.9% purity, while an in vitro study reported concentration-dependent, noncompetitive inhibition of human serum paraoxonase-1.
Capsazepine A3279: Reliable Assay Design
2026-09-22
Learn how Capsazepine (SKU A3279) can improve interpretation of TRPV1, viability, proliferation, and apoptosis experiments through defined pharmacology, solvent controls, and practical stock-handling guidance. The article distinguishes target-mediated effects from TRPM8, calcium-current, and cytotoxicity-related confounders.
Population PK/PD of RSD1235 in AF
2026-09-21
The reference study developed an integrated population pharmacokinetic–pharmacodynamic framework for vernakalant hydrochloride injection in atrial fibrillation and atrial flutter. By relating plasma exposure to QTcF, systolic blood pressure, and conversion status, it clarified both the rapid cardioversion profile and the clinical variables most relevant to hypotension risk.
Dextromethorphan Hydrobromide in Neuroprotection Assays
2026-09-21
Build more informative excitotoxicity experiments with Dextromethorphan hydrobromide by separating NMDA receptor effects from voltage-operated ion-channel modulation. This workflow connects concentration-response screening, orthogonal neuronal readouts, and cerebral ischemia model design while clearly distinguishing product evidence from proposed starting conditions.
Tetraethylammonium chloride K+ Channel Assays
2026-09-20
Tetraethylammonium chloride (TEAC) offers a practical way to interrogate potassium-channel pore conduction, mutant-channel behavior, and vascular responses. This workflow connects TEAC pharmacology with 86Rb efflux, patch-clamp, insulin-release, and isolated-artery assays while emphasizing controls that prevent receptor and ion-channel mechanisms from being confused.
Mecamylamine Hydrochloride as a Circuit Probe
2026-09-19
Mecamylamine hydrochloride can turn broad cholinergic observations into testable receptor-level hypotheses. This article presents a confound-aware framework for applying mecamylamine to gut–brain, seizure, and neuropsychiatric disorder research.
Amikacin (BAY416651) Resistance Workflows
2026-09-18
Amikacin (BAY416651) supports more than routine susceptibility testing: it can connect bacterial protein synthesis inhibition with enzyme-specific resistance, plasmid localization, and transmission assays. This research-focused workflow combines practical stock handling with the molecular framework used to study carbapenem-resistant Enterobacter cloacae.
Verapamil in Hypoxia-Driven Inflammation
2026-09-18
Verapamil ((±)-Verapamil) provides a practical perturbation tool for testing how prolonged hypoxia engages the ROS/TXNIP/NLRP3 axis in urothelial cells. This guide translates the reference findings into an executable workflow while highlighting controls for calcium-channel, P-glycoprotein, solvent, and exposure-time confounding.
Lamotrigine: Sodium Channel Research Guide
2026-09-17
Lamotrigine is a high-purity sodium channel blocker research compound identified as 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine. Its reported 5-HT activity, solubility profile, and compatibility with neuronal and cardiomyocyte assays support controlled epilepsy and cardiac sodium current modulation studies.
CLCC1 and Herpesvirus Nuclear Egress
2026-09-17
A 2024 bioRxiv preprint identifies CLCC1 as an essential host factor for the membrane-fusion step of herpesvirus nuclear egress, linking viral capsid release to nuclear-envelope morphogenesis. Its CRISPR-screen and cell-biology findings provide a framework for distinguishing viral budding defects from post-budding fusion defects, while remaining subject to the limitations of an unreviewed study.
3720 records 6/248 page Previous Next First page 上5页 678910 下5页 Last page